Herbalife Ltd. reported its financial results for the first quarter of 2026. Net sales were up 7.8% year-over-year to $1.3 billion. Adjusted EBITDA was $175.7 million with a diluted EPS of $0.57. Net cash provided by operating activities was $113.8 million with capital expenditures of $10.9 million.
“We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing,” said Stephan Gratziani, Herbalife CEO. “At the same time, we took further strategic actions to build on Herbalife’s deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation.”
Gross profit margin was 77.9%, down slightly from 78.3% in Q1 2025. Net income was $61.9 million, with net income margin of 4.7% and adjusted net income of $69 million.
In April, the company completed a $1.45 billion senior secured debt refinancing that is expected to result in approximately $45 million in annual cash interest savings.
“We delivered net sales growth and adjusted EBITDA above our guidance for the quarter,” said John DeSimone, Herbalife Chief Financial Officer. “We were also pleased to complete our $1.45 billion senior secured debt refinancing in April, achieving our pricing objectives, meaningfully reducing interest expense, extending our maturity profile and further strengthening our balance sheet and financial flexibility.”
During the quarter, Herbalife acquired Bioniq’s core personalized nutrition business assets for $55 million, payable over five years, of which $10 million was paid subsequent to closing and provides up to $95 million in contingent payments based on future Bioniq product sales performance. Herbalife also acquired a call option to acquire Bioniq LAB, a platform based on small molecules and peptides, which would provide Herbalife with strategic flexibility to evaluate potential longer-term opportunities in the segment in a capital-efficient manner.
“Personalization has long been foundational to Herbalife’s business, and our history is defined by innovation, a forward-looking mindset and a willingness to evolve alongside consumer needs,” Gratziani said. “Our recent acquisitions of Pro2col, Link BioSciences, Pruvit and Bioniq expand our personalization ecosystem, enabling an enhanced and differentiated experience for both customers and distributors and accelerating our evolution into the world’s premier health and wellness company, community and platform.”
Asia Pacific continued to be a strong growth driver for the company, reporting $495.8 million in revenue, a 20.8% year-over-year increase. Latin America also reported growth, with $242 million in revenue, a 6.8% increase over the first quarter of last year.
